Joel Beatty
Stock Analyst at Baird
(2.34)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
EDIT Editas Medicine | Maintains: Outperform | 4 6 | 2.2 | 172.73% | 5 | Aug 13, 2025 | |
COGT Cogent Biosciences | Maintains: Neutral | 7 9 | 10.93 | -17.66% | 6 | Jul 8, 2025 | |
SAGE Sage Therapeutics | Maintains: Neutral | 7 9 | 8.68 | 3.69% | 5 | Jun 20, 2025 | |
ELF e.l.f. Beauty | Maintains: Outperform | 110 145 | 111.59 | 29.94% | 7 | Jun 6, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Outperform | 28 31 | 24.83 | 24.85% | 4 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 38 24 | 20.36 | 17.88% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 58 50 | 18.93 | 164.13% | 2 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 680 680 | 638.76 | 6.46% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 29 | 13.91 | 108.48% | 2 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 66 | 43.3 | 52.42% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 167 155 | 110.76 | 39.94% | 4 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 160 162 | 103.95 | 55.84% | 5 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 38 41 | 26.55 | 54.43% | 3 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 10 | 3.79 | 163.85% | 2 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 27 16 | 9.98 | 60.32% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 16 | 6.43 | 148.83% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 117 73 | 44.96 | 62.37% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 32 | 19.69 | 62.52% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 75 | 38.56 | 94.5% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 3 11 | 7.81 | 40.85% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 7 | 1.7 | 311.76% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 72 65 | 56.8 | 14.44% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 112 127 | 129.46 | -1.9% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 60 | n/a | n/a | 2 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 68 72 | 27.39 | 162.87% | 4 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 540 240 | 5.13 | 4578.36% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 5 | 1.35 | 233.33% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 103 | 131.87 | -21.89% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | 9.64 | 159.34% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11 9 | n/a | n/a | 2 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | 28 | 0% | 3 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 28 | 12.5 | 124% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | n/a | n/a | 1 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 60 | n/a | n/a | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 16 | 2.4 | 566.67% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | 8.54 | -18.03% | 1 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 2 | 2.05 | -39.02% | 2 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 44 | 1.69 | 2503.55% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 58 | 17.2 | 237.21% | 6 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 24 | 22.84 | 5.08% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 18 | 11.39 | 58.03% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 6 | 2.33 | 157.51% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 46 31 | 1.28 | 2321.88% | 3 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 36 28 | 4.28 | 554.21% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 170 175 | 434.89 | -59.76% | 2 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 | 4.18 | 234.93% | 8 | Jan 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 108 | 17.95 | 501.67% | 7 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 74 | n/a | n/a | 2 | Oct 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 78 | 40.84 | 90.99% | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 440 160 | n/a | n/a | 2 | Jun 11, 2020 |